Skip to main content

Ketamine Oral Rinse in the Management of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy

This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.

Status
planned
Phase
Phase 2
Institution
University of Oklahoma
Principal investigator
Rusha Patel, MD
Start date
2026-06-01
End date
2027-11-01
Registry ID
NCT06660017

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.